Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 260Carcinoma, Non-Small-Cell Lung 125Glioblastoma 105Breast Neoplasms 104Ovarian Neoplasms 96Carcinoma, Hepatocellular 88Brain Neoplasms 71Rectal Neoplasms 69Neoplasm Metastasis 69Lung Neoplasms 65Colonic Neoplasms 58Neoplasms 57Glioma 52Fallopian Tube Neoplasms 44Carcinoma, Renal Cell 36Gliosarcoma 31Pancreatic Neoplasms 30Melanoma 27Liver Neoplasms 26Stomach Neoplasms 21Astrocytoma 21Adenocarcinoma of Lung 21Recurrence 20Kidney Neoplasms 19Colorectal Cancer Metastatic 17Triple Negative Breast Neoplasms 16Esophageal Neoplasms 15Uterine Cervical Neoplasms 14Sarcoma 13Prostatic Neoplasms 13

Interventions

Paclitaxel 10Surveys and Questionnaires 6Cisplatin 6Carboplatin 5pembrolizumab 4Brachytherapy 4Hyperthermic Intraperitoneal Chemotherapy 3Gemcitabine 3Doxorubicin 3Docetaxel 3olaparib 2niraparib 2durvalumab 2Topotecan 2Taxes 2Standard of Care 2Sentinel Lymph Node Biopsy 2Saline Solution 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Music Therapy 2Mitomycin 2Letrozole 2Imagery, Psychotherapy 2Hysterectomy 2Exercise 2Everolimus 2Blood Specimen Collection 2ulipristal acetate 1temsirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Uterine Neoplasms × Bevacizumab × Clear all
NCT00626561 2014-07-07

Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled 2 charts
Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡